var aids = "<h5>Acquired immunodeficiency syndrome (AIDS)</h5> <p class=\'tooltxt\'>acquired immunodeficiency syndrome (AIDS) The most advanced stages of infection with HIV.<sup>1</sup></p>";

var albumin_us = "<h5>Albumin</h5> <p class=\'tooltxt\'>An essential protein found in human plasma that accounts for about 50 to 60 percent of plasma proteins.<sup>2</sup> Each molecule is composed of three units, or domains, which function together to give albumin its unique binding properties.<sup>3</sup> It is the primary agent responsible for maintaining osmotic pressure of the blood, and for transport of fatty acids, hormones, enzymes, and therapeutic drugs.<sup>4</sup> Albumin is primarily responsible for 75 to 80 percent of plasma's normal colloid oncotic pressure.<sup>2</sup> Albumin supplementation restores intravascular volume in an attempt to maintain cardiac output and colloid osmotic pressure. When plasma volume is drastically reduced, albumin may help restore the losses.<sup>2</sup></p>";

var albumin = "<h5>Albumin</h5> <p class=\'tooltxt\'>An essential protein found in human plasma that accounts for about 50 to 60 percent of plasma proteins.<sup>2</sup> Each molecule is composed of three units, or domains, which function together to give albumin its unique binding properties.<sup>3</sup> It is the primary agent responsible for maintaining osmotic pressure of the blood, and for transport of fatty acids, hormones, enzymes, and therapeutic drugs.<sup>4</sup> Albumin is primarily responsible for 75 to 80 percent of plasma's normal colloid oncotic pressure.<sup>2</sup> Albumin supplementation restores intravascular volume in an attempt to maintain cardiac output and colloid osmotic pressure. When plasma volume is drastically reduced, albumin may help restore the losses.<sup>2</sup></p>";


var allo = "<h5>Allogeneic bone marrow transplantation</h5> <p class=\'tooltxt\'>Donor marrow received that is antigenically distinct.<sup>5</sup></p>";


var aatd = "<h5>Alpha-1 antitrypsin deficiency (AATD)</h5> <p class=\'tooltxt\'> A genetic condition in which AAT is not released from the liver into the blood. As a result, the affected person does not have enough AAT throughout the body. Some individuals with AAT deficiency are not affected, but other individuals develop liver problems like cirrhosis and/or lung problems like emphysema.<sup>6</sup></p>";


var aat = "<h5>Alpha-1 antitrypsin (AAT) </h5> <p class=\'tooltxt\'>A protein made in the liver that is normally released into the blood. AAT functions to protect delicate body tissues from being destroyed by tissue-digesting enzymes that can damage cells.<sup>6</sup></p>";

var alz = "<h5>Alzheimer&#8217;s disease</h5> <p class=\'tooltxt\'>Characterized by multiple symptoms, spanning from some memory loss to impairment of daily living. <sup>5</sup></p>";


var antibody = "<h5>Antibody</h5> <p class=\'tooltxt\'>A protein produced by blood plasma cells that binds specifically to substances foreign to the body. Once bound, the antibody can lead to the destruction or inactivation of the foreign substance.<sup>5</p>";


var at3 = "<h5>Antithrombin III (AT III)</h5> <p class=\'tooltxt\'>A protein of normal plasma and extravascular sites. It inactivates thrombin and inhibits certain coagulation factors.<sup>5</sup></p>";


var bcll = "<h5>B-cell chronic lymphocytic leukemia (B-CLL)</h5> <p class=\'tooltxt\'>Cancer of the white blood cells (WBC, lymphocytes); it causes a slow increase in the number of WBCs called B cells in the bone marrow.<sup>5</sup> Symptoms can include hypogammaglobulinemia and/or recurrent bacterial infections.<sup>7</sup> </p>";


var coag = "<h5>Coagulation</h5> <p class=\'tooltxt\'>Another word for clotting of the blood. It is the process in which liquid blood is changed into a jelly-like substance to seal an injured blood vessel.<sup>1</sup></p>";


var cvid = "<h5>Common Variable Immunodeficiency (CVID)</h5> <p class=\'tooltxt\'>A disorder characterized by low levels of serum immunoglobulins (antibodies) and an increased susceptibility to infections. The genetic causes of the low levels of serum immunoglobulins are not known in most cases. It is a relatively &quot;common&quot; form of immunodeficiency, but the degree and type serum-immunoglobulin deficiency as well as the clinical course is &quot;variable&quot; from patient to patient.<sup>8</sup></p>";

var cisn = "<h5>Coumarin-induced skin necrosis</h5> <p class=\'tooltxt\'>A microthrombotic lesion found in central fatty areas of the body. Patients with congenital protein C deficiency are particularly susceptible. <sup>9-11</sup></p>";


var gbs = "<h5>Guillain-Barr&#233; syndrome</h5> <p class=\'tooltxt\'>A rare autoimmune disorder in which the peripheral nervous system is attacked by the body's immune system. Initial symptoms include degrees of weakness or tingling sensations in the legs, and can spread to the arms and upper body. In life-threatening cases these symptoms can intensify to near-total paralysis and may require a respirator to assist with breathing. However, most patients recover from even severe cases of Guillain-Barr&#233; syndrome, but may continue to have some degree of weakness.<sup>12</sup></p>";



var hiv = "<h5>Human immunodeficiency virus (HIV) </h5> <p class=\'tooltxt\'>A virus that kills or damages cells of the body's immune system.</p>";


var hi = "<h5>Humoral immunity</h5> <p class=\'tooltxt\'>Refers to antibody production and multiple related processes as well as antibody effector functions.<sup>13</sup></p>";


var hypog = "<h5>Hypogammaglobulinemia</h5> <p class=\'tooltxt\'>Lower than normal levels of gamma globulins or immunoglobulins (or antibodies) in the blood.<sup>8</sup></p>";


var hypov = "<h5>Hypovolemia</h5> <p class=\'tooltxt\'>An abnormal decrease in blood volume or, strictly speaking, an abnormal decrease in the volume of blood plasma. From hypo- + volume + emia (blood).<sup>14</sup></p>";



var itp = "<h5>Immune thrombocytopenic purpura (ITP)</h5> <p class=\'tooltxt\'> An autoimmune disease characterized by a low blood platelet count.<sup>15</sup> Patients may experience bruising, nose bleeds, or bleeding gums when platelet counts are low.</p>";


var immuno = "<h5>Immunoglobulins (IgG) </h5> <p class=\'tooltxt\'>Any of the structurally related glycoproteins that function as antibodies. They are divided into 5 classes on the basis of structure and biological activity: IgA, IgD, IgE, IgG, and IgM.</p>";

var eu_immuno = "<h5>Immunoglobulins (IgG) </h5> <p class=\'tooltxt\'>Any of the structurally related glycoproteins that function as antibodies. They are divided into 5 classes on the basis of structure and biological activity: IgA, IgD, IgE, IgG, and IgM. IVIg consists mainly of IgG.</p>";


var intra  = "<h5>Intravenous</h5> <p class=\'tooltxt\'>A route for administration of medications and fluids via the bloodstream through a vein.<sup>1</sup> </p>";


var igiv = "<h5>Intravenous immunoglobulin (IGIV)</h5> <p class=\'tooltxt\'>Glycoproteins that function as antibodies administered via the bloodstream.<sup>1</sup></p>";

var IVIG = "<h5>Intravenous immunoglobulin (IVIG)</h5> <p class=\'tooltxt\'>Glycoproteins that function as antibodies administered via the bloodstream.<sup>1</sup></p>";


var kd = "<h5>Kawasaki disease</h5> <p class=\'tooltxt\'>A disease whose symptoms include coronary artery aneurysms and other coronary artery abnormalities.<sup>16</sup></p>";


var ks = "<h5>Kawasaki syndrome</h5> <p class=\'tooltxt\'>A disease whose symptoms include coronary artery aneurysms and other coronary artery abnormalities.<sup>17</sup></p>";


var mmn = "<h5>Multifocal motor neuropathy (MMN)</h5> <p class=\'tooltxt\'>A rare slow-progressing disease characterized by asymmetrical muscle weakness and muscle atrophy with autoimmune-mediated pathogenesis.<sup>1</sup></p>";


var pep = "<h5>Post-exposure prophylaxis</h5> <p class=\'tooltxt\'>A medical intervention to prevent tetanus infection in individuals who are at risk, usually through wound contamination.<sup>18,19</sup></p>";


var pi = "<h5>Primary immunodeficiency (PI)</h5> <p class=\'tooltxt\'>Immunodeficiency intrinsic to cells and tissues of the immune system, and not due to another illness, medication or outside agent damaging the immune system. IGIV therapy is used to treat PIs associated with defects in humorol immunity (ie, a lack of antibody production). These include, but are not limited to, Common Variable Immunodeficiency, X-Linked Agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency. IGIV therapy is not effective for some types of PI, such as selective IgA deficiency or complement deficiencies.<sup>20</sup> To date there are over 150 PIs classified by the World Health Organization (WHO).<sup>21</sup></p>";

var pid = "<h5>Primary immunodeficiencies (PID)</h5> <p class=\'tooltxt\'>Immunodeficiencies intrinsic to cells and tissues of the immune system, and not due to another illness, medication or outside agent damaging the immune system. IVIg therapy is used to treat PIDs associated with defects in humorol immunity (ie, a lack of antibody production). These include, but are not limited to, Common Variable Immunodeficiency, X-Linked Agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency. IVig therapy is not effective for some types of PI, such as selective IgA deficiency or complement deficiencies.<sup>20</sup> To date there are over 150 PIDs classified by the World Health Organization (WHO).<sup>21</sup></p>";


var pf = "<h5>Purpura fulminans</h5> <p class=\'tooltxt\'>Bruising, necrosis and discoloring of the skin as a result of severe clotting of small blood vessels in the skin. <sup>22,23</sup></p>";


var si = "<h5>Secondary immunodeficiency (SI)</h5> <p class=\'tooltxt\'>A number of conditions such as malignancies, particularly those of the haematopoietic and lymphoreticular systems, metabolic disease, malnutrition, burns or severe infection can also cause defective immune function and poor antibody response. In particular, IGIV therapies, are used to treat chronic lymphatic leukemia (CLL) and myeloma (MM).<sup>24</sup> These patients may benefit from immunoglobulin replacement therapy in addition to standard treatment of their primary disease.</p>";

var sid = "<h5>Secondary immunodeficiencies (SID)</h5> <p class=\'tooltxt\'>Patients with SID's can be susceptible to a weakening of their immune systems and as a result recurrent infections due to low antibody levels. A number of conditions such as malignancies, particularly those of the haematopoietic and lymphoreticular systems, metabolic disease, malnutrition, burns or severe infection can also cause defective immune function and poor antibody response. <sup>1,2</sup> These conditions include but are not limited to chronic lymphatic leukemia (CLL) and myeloma (MM).</p>";

var eu_si = "<h5>Secondary immunodeficiency (SI)</h5> <p class=\'tooltxt\'>Patients with SI's can be susceptible to a weakening of their immune systems and as a result recurrent infections due to low antibody levels. A number of conditions such as malignancies, particularly those of the haematopoietic and lymphoreticular systems, metabolic disease, malnutrition, burns or severe infection can also cause defective immune function and poor antibody response. <sup>1,2</sup> These conditions include but are not limited to chronic lymphatic leukemia (CLL) and myeloma (MM).</p>";


var scid = "<h5>Severe combined immunodeficiency (SCID)</h5> <p class=\'tooltxt\'>a genetic disorder in which both B cells and T cells of the adaptive immune system are crippled, due to a defect in one of several possible genes. SCID is a severe form of heritable immunodeficiency.<sup>25</sup></p>";


var spc = "<h5>Severe congenital protein C deficiency </h5> <p class=\'tooltxt\'> A rare genetic disorder that interferes with Protein C production, resulting in either Protein C deficit or malfunction. Currently, there are fewer than 20 known cases of severe congenital Protein C deficiency in the United States.<sup>26</sup></p>";

var eu_spc = "<h5>Severe congenital protein C deficiency </h5> <p class=\'tooltxt\'> A rare genetic disorder that interferes with Protein C production, resulting in either Protein C deficit or malfunction.</p>";


var subq = "<h5>Subcutaneous</h5> <p class=\'tooltxt\'>Administration of a product under the skin.<sup>1</sup></p>";


var tet = "<h5>Tetanus, clinically manifested tetanus</h5> <p class=\'tooltxt\'>An acute and often fatal infectious disease caused by an anaerobic spore-forming bacillus which often enters the body through contaminated puncture wounds. Other portals of entry can include burns, surgical wounds, and cutaneous ulcers. Clinically manifested tetanus presents as local muscle spasms in areas contiguous to an infected wound.<sup>27</sup></p>";


var vt = "<h5>Venous thrombosis</h5> <p class=\'tooltxt\'>Blood clot in the vein.<sup>22,23</sup></p>";


var was = "<h5>Wiskott-Aldrich syndrome</h5> <p class=\'tooltxt\'>An inherited defect of the immune system, caused by a mutation in the WAS gene located on the X chromosome.<sup>28</sup></p>";


var xla = "<h5>X-Linked Agammaglobulinemia</h5> <p class=\'tooltxt\'>A PI disorder in which males are susceptible to bacterial infection, due to a mutation in the Btk gene which leads to a lack of antibody production.<sup>5</sup> The disorder is X-linked as it is on the X chromosome, and is almost entirely limited to the sons of asymptomatic female carriers.<sup>8</sup></p>";

var eu_xla = "<h5>X-Linked Agammaglobulinemia</h5> <p class=\'tooltxt\'>A PID disorder in which males are susceptible to bacterial infection, due to a mutation in the Btk gene which leads to a lack of antibody production.<sup>5</sup> The disorder is X-linked as it is on the X chromosome, and is almost entirely limited to the sons of asymptomatic female carriers.<sup>8</sup></p>";
 
var exit = "<h5 class=\'exit\'>You are now leaving the <br/>BioTherapeutics website.</h5> <p class=\'tooltxt_exit\'>Baxter is not responsible for the privacy policy, the content or the accuracy of any web site accessed through a link on the biotherapeutics.com site. A link to other web sites does not constitute an endorsement by Baxter of the linked site, its products or services.</p>";

var exit_eu = "<h5 class=\'exit\'>Dear visitor! You are leaving the European BioTherapeutics webpage.</h5> <p class=\'tooltxt_exit\'>Please note that information outside this page may not be appropriate or applicable to a European audience.</p>";

var enter_us = "<h5 class=\'exit\'>You are now entering the<br/> BioTherapeutics US site.</h5> <p class=\'tooltxt_exit\'>This site is intended for use only by US residents.</p>";

var lisc_eu = "<h5 class=\'exit\'>Licenses and licensing conditions may vary from country to country.</h5><p class=\'tooltxt_exit\'> Please always consult your country specific SPC or package leaflet.</p>";